About Peptides Plus

What this site is

Peptides Plus is a clinical reference for health-focused adults and practitioners researching peptide protocols. It is not a research database — Peptide Therapy Index handles the raw science. It is not a lifestyle blog. It sits precisely in between: evidence-grounded, condition-specific, and written for someone who is going to make a real decision about their health, not write a literature review.

Readers arrive with a specific condition, protocol question, or safety concern. They leave with a clear, evidence-grounded answer they can act on or discuss with their healthcare provider. That is the editorial purpose of this site.

The Protocol Maturity Badge

Every post on Peptides Plus carries a Protocol Maturity Badge — a trust signal that tells readers what the evidence means for practical use, not just what type of evidence exists. The five levels are:

• Established Protocol Multiple human studies, dosing ranges consistent, safety profile documented.
• Emerging Protocol Human data exists, dosing still being studied, used in practice but evidence maturing.
• Research Stage Predominantly preclinical; human data limited or absent; protocol is theoretical.
• Case-Based Derived primarily from case reports and practitioner observation; no controlled data.
• Contraindicated Areas Noted Protocol exists but specific contraindications or safety flags warrant explicit attention.

This badge is distinct from a study-type classification. A post can have strong evidence (RCT-quality) and still be labelled Emerging Protocol because dosing hasn't converged in the literature. The distinction matters for anyone trying to make a practical decision.

Editorial standards

Every post includes a structured safety section — adverse effects, contraindications, and evidence gaps — placed before the FAQ, always present, always structured. Where no adverse effects are documented, that is stated explicitly. Where contraindications exist, they are presented before dosing information.

The word "proven" does not appear on this site. Evidence is described accurately: preliminary, emerging, established. Uncertainty is acknowledged precisely. "The evidence here is preliminary" means the findings exist but have not been tested in controlled human trials. "No human data exists" means the only evidence is from animal models or cell culture.

Primary sources take precedence. Where a finding is described, the study it originates from is cited — not forum posts, podcasts, or secondary summaries.

No commercial interest

This site sells nothing. There are no affiliate links to peptide suppliers, compounding pharmacies, or any other commercial entity. There is no advertising. No content is sponsored. No payment influences editorial decisions in any direction.

Peptides Plus exists because health-seeking readers researching peptide protocols face the same information quality problem as the broader peptide research space: the available sources are dominated by sellers with a commercial interest in overstating the evidence. An independent site applying consistent editorial standards is a practical response to that problem.

What this site is not

This site does not provide medical advice and is not a substitute for clinical consultation. No content here should be used as the basis for a treatment decision without the involvement of a qualified healthcare professional who can assess individual circumstances. The protocol information presented here is descriptive — it describes what studies found and what practitioners have reported. It does not prescribe.

Correspondence

Clinician feedback, correction submissions, and protocol questions: contact@peptides-plus.com. Errors in protocol summaries are taken seriously and corrected promptly — if you have reviewed primary literature that contradicts a published summary, this is the right place to send it.